Protocol: CDISCPILOT01                                                                  Page  1 of 4 
Population: Safety 
Table 14-7.02 
Summary of Vital Signs Change from Baseline at End of Treatment 
 
 
End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 
visit). 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas                      21:06 Monday, June 26, 2006 
Measure 
Position 
Treatment
N 
Planned 
Relative 
Time 
n 
Mean
SD 
Median
Min.
Max. 
Systolic Blood 
Pressure(mmHg) 
AFTER LYING DOWN 
FOR 5 MINUTES 
 Placebo 86 Week 24 
58  -2.1 14.73  -4.0 -28.0  50.0 
 
 
 
 End of Trt. 83  -2.0 16.76  -4.0 -32.0  50.0 
 
 
 
 Xan.Low 84 Week 24 
27  -0.3 17.19   2.0 -48.0  30.0 
 
 
 
 End of Trt. 84  -3.1 16.57  -2.0 -48.0  34.0 
 
 
 
 Xan.High 84 Week 24 
30  -5.6 17.18  -7.0 -36.0  26.0 
 
 
 
 End of Trt. 82  -5.8 14.48  -8.0 -36.0  29.0 
 
 
AFTER STANDING 
FOR 1 MINUTE 
 Placebo 86 Week 24 
58  -1.7 16.87   0.0 -32.0  40.0 
 
 
 
 End of Trt. 83  -1.6 17.76   0.0 -46.0  48.0 
 
 
 
 Xan.Low 84 Week 24 
27  -0.1 17.73  -1.0 -30.0  48.0 
 
 
 
 End of Trt. 84  -2.8 17.40  -1.5 -52.0  48.0 
 
 
 
 Xan.High 84 Week 24 
30  -6.3 19.49  -9.0 -36.0  42.0 
 
 
 
 End of Trt. 82  -6.7 16.98  -8.0 -44.0  42.0 
 
 
AFTER STANDING 
FOR 3 MINUTES 
 Placebo 86 Week 24 
58  -1.0 15.80  -3.5 -36.0  38.0 
 
 
 
 End of Trt. 83  -2.5 16.61  -4.0 -40.0  48.0 
 
 
 
 Xan.Low 84 Week 24 
27  -0.1 16.20   0.0 -30.0  30.0 
 
 
 
 End of Trt. 83  -3.5 16.51  -4.0 -52.0  60.0 
 
 
 
 Xan.High 84 Week 24 
30  -9.0 16.88  -8.0 -40.0  30.0 

--- Page 2 ---
Protocol: CDISCPILOT01                                                                  Page  2 of 4 
Population: Safety 
Table 14-7.02 
Summary of Vital Signs Change from Baseline at End of Treatment 
 
 
End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 
visit). 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas                      21:06 Monday, June 26, 2006 
Measure 
Position 
Treatment
N 
Planned 
Relative 
Time 
n 
Mean
SD 
Median
Min.
Max. 
 
 
 
 End of Trt. 81  -8.3 15.21  -8.0 -40.0  30.0 
 
Diastolic Blood 
Pressure(mmHg) 
AFTER LYING DOWN 
FOR 5 MINUTES 
 Placebo 86 Week 24 
58  -0.8 10.82  -0.5 -18.0  41.0 
 
 
 
 End of Trt. 83  -1.0 10.99   0.0 -34.0  41.0 
 
 
 
 Xan.Low 84 Week 24 
27  -0.9  7.71  -2.0 -20.0  16.0 
 
 
 
 End of Trt. 84  -2.0  8.80  -2.0 -30.0  18.0 
 
 
 
 Xan.High 84 Week 24 
30  -2.2  9.20  -1.0 -20.0  21.0 
 
 
 
 End of Trt. 82  -3.1  8.79  -4.0 -24.0  21.0 
 
 
AFTER STANDING 
FOR 1 MINUTE 
 Placebo 86 Week 24 
58  -2.3 10.08  -4.0 -23.0  24.0 
 
 
 
 End of Trt. 83  -2.8 10.17  -2.0 -34.0  24.0 
 
 
 
 Xan.Low 84 Week 24 
27   1.0  7.30   2.0 -20.0  18.0 
 
 
 
 End of Trt. 84  -1.2  8.93   0.0 -30.0  20.0 
 
 
 
 Xan.High 84 Week 24 
30  -2.3 10.85  -7.0 -18.0  22.0 
 
 
 
 End of Trt. 82  -2.1 12.10  -2.0 -34.0  28.0 
 
 
AFTER STANDING 
FOR 3 MINUTES 
 Placebo 86 Week 24 
58  -2.3  9.56  -3.5 -22.0  20.0 
 
 
 
 End of Trt. 83  -2.7  9.36  -2.0 -30.0  20.0 
 
 
 
 Xan.Low 84 Week 24 
27  -1.6  8.29   0.0 -20.0  10.0 
 
 
 
 End of Trt. 83  -1.8  9.69  -1.0 -24.0  38.0 

--- Page 3 ---
Protocol: CDISCPILOT01                                                                  Page  3 of 4 
Population: Safety 
Table 14-7.02 
Summary of Vital Signs Change from Baseline at End of Treatment 
 
 
End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 
visit). 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas                      21:06 Monday, June 26, 2006 
Measure 
Position 
Treatment
N 
Planned 
Relative 
Time 
n 
Mean
SD 
Median
Min.
Max. 
 
 
 
 Xan.High 84 Week 24 
30  -2.1  9.77  -3.5 -20.0  16.0 
 
 
 
 End of Trt. 81  -2.6 10.81  -2.0 -40.0  27.0 
 
Pulse(bpm) 
AFTER LYING DOWN 
FOR 5 MINUTES 
 Placebo 86 Week 24 
58  -0.3  8.77  -1.0 -24.0  24.0 
 
 
 
 End of Trt. 83  -0.9  8.69  -1.0 -24.0  24.0 
 
 
 
 Xan.Low 84 Week 24 
27  -1.6 10.53   0.0 -24.0  25.0 
 
 
 
 End of Trt. 84  -1.0 11.12  -0.5 -24.0  32.0 
 
 
 
 Xan.High 84 Week 24 
30  -2.0 11.16  -2.0 -34.0  20.0 
 
 
 
 End of Trt. 82  -1.7  8.95  -2.0 -34.0  20.0 
 
 
AFTER STANDING 
FOR 1 MINUTE 
 Placebo 86 Week 24 
58  -1.7 11.72   0.5 -53.0  18.0 
 
 
 
 End of Trt. 83  -1.8 11.05  -1.0 -53.0  20.0 
 
 
 
 Xan.Low 84 Week 24 
27  -1.3  9.05   0.0 -20.0  12.0 
 
 
 
 End of Trt. 84  -0.5 11.69   0.0 -24.0  34.0 
 
 
 
 Xan.High 84 Week 24 
30  -1.8 13.41  -3.0 -36.0  20.0 
 
 
 
 End of Trt. 82  -2.1 10.43  -1.5 -36.0  22.0 
 
 
AFTER STANDING 
FOR 3 MINUTES 
 Placebo 86 Week 24 
58  -1.5 10.47   0.0 -46.0  14.0 
 
 
 
 End of Trt. 83  -1.0  9.89   0.0 -46.0  18.0 
 

--- Page 4 ---
Protocol: CDISCPILOT01                                                                  Page  4 of 4 
Population: Safety 
Table 14-7.02 
Summary of Vital Signs Change from Baseline at End of Treatment 
 
 
End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 
visit). 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas                      21:06 Monday, June 26, 2006 
Measure 
Position 
Treatment
N 
Planned 
Relative 
Time 
n 
Mean
SD 
Median
Min.
Max. 
 
 
 Xan.Low 84 Week 24 
27  -2.1  8.77  -2.0 -20.0  16.0 
 
 
 
 End of Trt. 83  -0.7 10.73  -1.0 -22.0  29.0 
 
 
 
 Xan.High 84 Week 24 
30  -2.7 11.12  -2.0 -40.0  14.0 
 
 
 
 End of Trt. 81  -1.9  9.49  -1.0 -40.0  20.0 
 
 
